Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

19.29 +5.60 (+40.91%)
Streaming Delayed Price Updated: 12:49 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pulse Biosciences, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
PLSE Stock Earnings: Pulse Biosciences Reported Results for Q4 2023 ↗
Pulse Biosciences just reported results for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Announces Plans to Initiate a Rights Offering
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Earnings Scheduled For March 28, 2024 ↗
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
News headline image
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart... 
Via Benzinga
News headline image
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday? ↗
Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758... 
Via Benzinga
News headline image
$10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying ↗
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Insiders Buying Dave And 2 Other Stocks ↗
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Insiders Buying Westrock Coffee And 3 Other Stocks ↗
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.... 
Via Benzinga
News headline image
Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones falling around 90 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 13, 2023 ↗
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Circumferential Catheter System to be Featured in a Presentation at the Global EP Summit
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase
From Pulse Biosciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.